Clinical Trials Directory

Trials / Unknown

UnknownNCT05052424

Immun Response in Children With MIS-C

Cellular and Molecular Characterization of the Immune Response in Children and Adolescents With Inflammatory Syndrome in Children (MIS-C)

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
University of Cologne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multi-system inflammatory syndrome in children (MIS-C) is a post-viral inflammatory vasculopathy of children and adolescents following Covid-19 infection. It affects one of 1000-5000 children. Latency between mild or asymptomatic Covid-19 infection and MIS-C is 4-6 weeks. The immune response in MIS-C seems to be dysregulated and different from that during acute SARS-CoV-2 infection. The investigators are planning to investigate the immune response in children with MIS-C. RNA and protein expression of cytokines and immune cell-related markers will be determined via multiplex ELISA, FACS, quantitative PCR, RNAseq, and Western blot. The use of highly sensitive multiplex methods will allow for the analysis of a large number of parameters in the smallest possible amount of sample. Sample preparation and analysis will be performed in close collaboration with the Centre for Molecular Medicine Cologne (CMMC) and the Institute of Virology. With this project the investigators hope to identify risk factors for developing MIS-C and extend the knowledge on therapeutic options for the treatment of this condition.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnalysis of cytokines and immun cell related markersblood samples

Timeline

Start date
2021-09-01
Primary completion
2022-09-01
Completion
2022-12-01
First posted
2021-09-22
Last updated
2021-09-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05052424. Inclusion in this directory is not an endorsement.